Velocity Fund Partners

Scribenote is an AI-powered medical scribe tailored to help veterinarians by automating and streamlining the documentation process. Veterinary practices often struggle with extensive, time-consuming paperwork, leading to stress and inefficiencies. By utilizing artificial intelligence, Scribenote reduces the administrative burden, enabling veterinarians to focus more on patient care and less on paperwork.

MedMe Health is a patient care platform that assists pharmacists in scheduling, conducting, and tracking clinical services both virtually and on-site. The platform employs proprietary algorithms to streamline various medical services, including online scheduling, digital diagnosis, documentation filing, and automated follow-up appointments. By facilitating these processes, MedMe Health enables pharmacies to enhance their workflows, strengthen patient relationships, and diversify revenue opportunities within clinical services.

InClinica, Inc. is a global clinical contract research organization (CRO) that offers comprehensive clinical development and pharmaceutical research services to biotechnology and pharmaceutical companies. Founded in 2007 and based in Wayne, Pennsylvania, InClinica specializes in various therapeutic areas, including oncology, metabolic disease, cardiovascular, infectious disease, and women's health, among others. The company assists clients through all phases of clinical trials, with a particular focus on early-phase studies such as first-in-man and Phase 2 trials. InClinica serves a diverse clientele across North America, Europe, Asia, and Latin America, leveraging a senior management team with extensive experience in drug development. The company also operates regional offices in Kuala Lumpur, Malaysia, and has expanded its presence internationally.